Your browser doesn't support javascript.
loading
Identification of a long non-coding RNA regulator of liver carcinoma cell survival.
Rybakova, Yulia; Gonzalez, John T; Bogorad, Roman; Chauhan, Vikash P; Dong, Yize L; Whittaker, Charles A; Zatsepin, Timofei; Koteliansky, Victor; Anderson, Daniel G.
Afiliação
  • Rybakova Y; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Gonzalez JT; Skolkovo Institute of Science and Technology, Moscow, 121205, Russia.
  • Bogorad R; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Chauhan VP; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Dong YL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Whittaker CA; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Zatsepin T; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Koteliansky V; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Anderson DG; Skolkovo Institute of Science and Technology, Moscow, 121205, Russia.
Cell Death Dis ; 12(2): 178, 2021 02 15.
Article em En | MEDLINE | ID: mdl-33589614
ABSTRACT
Genomic studies have significantly improved our understanding of hepatocellular carcinoma (HCC) biology and have led to the discovery of multiple protein-coding genes driving hepatocarcinogenesis. In addition, these studies have identified thousands of new non-coding transcripts deregulated in HCC. We hypothesize that some of these transcripts may be involved in disease progression. Long non-coding RNAs are a large class of non-coding transcripts which participate in the regulation of virtually all cellular functions. However, a majority of lncRNAs remain dramatically understudied. Here, we applied a pooled shRNA-based screen to identify lncRNAs essential for HCC cell survival. We validated our screening results using RNAi, CRISPRi, and antisense oligonucleotides. We found a lncRNA, termed ASTILCS, that is critical for HCC cell growth and is overexpressed in tumors from HCC patients. We demonstrated that HCC cell death upon ASTILCS knockdown is associated with apoptosis induction and downregulation of a neighboring gene, protein tyrosine kinase 2 (PTK2), a crucial protein for HCC cell survival. Taken together, our study describes a new, non-coding RNA regulator of HCC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / RNA Longo não Codificante / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / RNA Longo não Codificante / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article